Medtech's High-Earners: 2016 Executive Payouts Boosted By Bonuses, Stock Awards
Executive Summary
A Medtech Insight analysis of the highest-earning CEOs among the top medtech companies in last year's MTI 100 company league table shows that these individuals benefited mainly from stock and options holdings, as well as very generous incentive bonuses, bestowed upon them by their boards of directors. However, a couple of CEOs, including Zimmer Biomet's David Dvorak and Cardinal Health's George Barrett, who were rewarded fiscally for taking their companies to growth have had their leadership challenged since then.
You may also be interested in...
George Barrett To Step Down As Cardinal Health CEO
Two days before Cardinal Health shareholder's meeting this week – including a planned crucial vote on Chairman and CEO George Barrett's continued leadership– Cardinal announced that Barrett will step down as CEO Jan. 1, to be replaced by Chief Financial Officer Mike Kaufmann. Barrett, meanwhile, will continue as executive chairman of the board of directors for another year.
Teamsters Ask Stockholders To Replace Cardinal Health Chairman
The International Brotherhood of Teamsters say that Cardinal Health CEO George Barrett failed to set the correct "tone at the top" while the firm became embroiled in the opioid epidemic and allegedly overpaid its chief compliance officer for illicit sales. The group is asking shareholders to appoint an independent board chairman, stripping Barrett of the role.
US Approvals Analysis: Abbott Leads Another Strong Month For Novel Approvals
Abbott Laboratories accounted for two of five original PMA approvals recorded by US FDA in August. That update and more from Medtech Insight's Approvals Tracker.